Literature DB >> 22870495

Is there a future for selective estrogen-receptor modulators in osteoporosis?

Roberto C Güerri-Fernández, Adolfo Diez-Perez.   

Abstract

Entities:  

Year:  2012        PMID： 22870495      PMCID： PMC3383523          DOI： 10.1177/1759720X11435677

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN： 1759-720X            Impact factor:   5.346


× No keyword cloud information.
  29 in total

Review 1.  Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

Authors:  B Lawrence Riggs; Lynn C Hartmann
Journal:  N Engl J Med       Date:  2003-02-13       Impact factor: 91.245

2.  Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.

Authors:  Elizabeth Barrett-Connor; Lori Mosca; Peter Collins; Mary Jane Geiger; Deborah Grady; Marcel Kornitzer; Michelle A McNabb; Nanette K Wenger
Journal:  N Engl J Med       Date:  2006-07-13       Impact factor: 91.245

3.  Lasofoxifene in postmenopausal women with osteoporosis.

Authors:  Steven R Cummings; Kristine Ensrud; Pierre D Delmas; Andrea Z LaCroix; Slobodan Vukicevic; David M Reid; Steven Goldstein; Usha Sriram; Andy Lee; John Thompson; Roisin A Armstrong; David D Thompson; Trevor Powles; Jose Zanchetta; David Kendler; Patrick Neven; Richard Eastell
Journal:  N Engl J Med       Date:  2010-02-25       Impact factor: 91.245

Review 4.  Epidemiology of hip fractures.

Authors:  P Kannus; J Parkkari; H Sievänen; A Heinonen; I Vuori; M Järvinen
Journal:  Bone       Date:  1996-01       Impact factor: 4.398

5.  Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group.

Authors:  S T Harris; N B Watts; H K Genant; C D McKeever; T Hangartner; M Keller; C H Chesnut; J Brown; E F Eriksen; M S Hoseyni; D W Axelrod; P D Miller
Journal:  JAMA       Date:  1999-10-13       Impact factor: 56.272

6.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

7.  Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.

Authors:  Sylvia Wassertheil-Smoller; Susan L Hendrix; Marian Limacher; Gerardo Heiss; Charles Kooperberg; Alison Baird; Theodore Kotchen; J David Curb; Henry Black; Jacques E Rossouw; Aaron Aragaki; Monika Safford; Evan Stein; Somchai Laowattana; W Jerry Mysiw
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

8.  Effect of tamoxifen on bone mineral density measured by dual-energy x-ray absorptiometry in healthy premenopausal and postmenopausal women.

Authors:  T J Powles; T Hickish; J A Kanis; A Tidy; S Ashley
Journal:  J Clin Oncol       Date:  1996-01       Impact factor: 44.544

9.  The effect of hip fracture on mortality, hospitalization, and functional status: a prospective study.

Authors:  F D Wolinsky; J F Fitzgerald; T E Stump
Journal:  Am J Public Health       Date:  1997-03       Impact factor: 9.308

10.  The aftermath of hip fracture: discharge placement, functional status change, and mortality.

Authors:  Suzanne E Bentler; Li Liu; Maksym Obrizan; Elizabeth A Cook; Kara B Wright; John F Geweke; Elizabeth A Chrischilles; Claire E Pavlik; Robert B Wallace; Robert L Ohsfeldt; Michael P Jones; Gary E Rosenthal; Fredric D Wolinsky
Journal:  Am J Epidemiol       Date:  2009-10-04       Impact factor: 4.897
View more
  2 in total

1.  Jiawei Yanghe Decoction Regulates Bone-Lipid Balance through the BMP-SMAD Signaling Pathway to Promote Osteogenic Differentiation of Bone Mesenchymal Stem Cells.

Authors:  Yunfeng Luo; Hanting Xia; Jiacai Wang; Qian Hu; Yinghua Luo; Jiangyuan Liu; Zhijun Yang; Wei Li; Hongyu Wang; Fuwei Li; Zhaochong Mao; Wenlong Yang; Fengyun Yang
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-20       Impact factor: 2.650

2.  Bone selective protective effect of a novel bone-seeking estrogen on trabecular bone in ovariectomized rats.

Authors:  Qiang Zhao; Xiaodong Liu; Lianfang Zhang; Xing Shen; Jin Qi; Jinshen Wang; Niandong Qian; Lianfu Deng
Journal:  Calcif Tissue Int       Date:  2013-06-19       Impact factor: 4.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.